Member Info for ChasPB

Last Years RNS's relating to Year End 2019 results were:

In 2020:
30th June - Publication of Annual Report
14th May - Final results for 31 Dec 2019
29th Apr - Notification of Publication of final Results

Therefore, could we see the Final Results and Outlook for 2021 some time in Mid May (as last year), and then the Full Audited Annual Results 29th June?

Same as last year.

Extension due to Covid situation for all companies

Thx Pedro.

Excellent - Lets hope so.

Could we see some BUYing now on FOMO in case we publish anytime from today onwards then.

Can anybody confirm that I'm reading this correctly please

Accounts
Required to publish accounts from 1 January to 31 December within 4 months under parent law.
(I think last year all companies were granted an extension if they needed it)

https://find-and-update.company-information.service.gov.uk/company/FC033649

Yup, and the £36m per Qtr averages to £400,000 per day, probably more now.

No debts with a growing Product range.

Loads of companies would like that!!!

Graham Mullis, Group CEO of Novacyt, commented:

"Novacyt remains focused on leveraging its innovative reputation and position in the rapidly changing COVID-19 testing market to continue to deliver value and support clinicians and laboratories in a global setting. Of note, following its launch, our PROmate™ test has been well received by users and opens up new opportunities for rapid PCR testing, including in private testing markets.

In addition, we look forward to presenting exciting long-term plans for Novacyt during Q2 this year as we continue to define our strategy for delivering sustainable, long-term growth."

How about a Share Buy Back?

5m shares would cost less than £20m

Wonder how many countries have current tests that can detect this Indian ‘Double’ variant?

There are 4 - 5 Billion people in Middle East + Asia, so if this spreads as quickly and powerfully as being mentioned, many countries could coming knocking.

Already it has doubled here in less than a week, how many cases in India this week alone? 1.5m?

A 'double mutant' variant of COVID-19 virus found in India is a cause of growing concern.

The variant, named B.1.617, has been found in more than 60% of the sequenced samples from Maharashtra and also detected in nine other states of the country, say news reports. The government has said higher transmissibility of this variant has not been established yet. The United Kingdom is the latest country to have discovered the "double mutation" variant in its region.

The 'double mutant' #COVID strain may have become the most prevalent strain in the recent cases of infection across #India.

https://twitter.com/i/events/1383065171132772352

One positive we might see is a token dividend to shareholders to reward our patience
************************************************************************************
Rather they spend £20m and do a share Buy Back of approx 5m shares.
That'll help the SP Up and panic the shorters into Buying, therefore helping the SP even further

NHS Covid-19 app update blocked for breaking Apple and Google's rules

An update to England and Wales's contact tracing app has been blocked for breaking the terms of an agreement made with Apple and Google.

The plan had been to ask users to upload logs of venue check-ins - carried out via poster barcode scans - if they tested positive for the virus. This could be used to warn others.

The update had been timed to coincide with the relaxation of lockdown rules.

But the two firms had explicitly banned such a function from the start.

Under the terms that all health authorities signed up to in order to use Apple and Google's privacy-centric contact-tracing tech, they had to agree not to collect any location data via the software.

As a result, Apple and Google refused to make the update available for download from their app stores last week, and have instead kept the old version live.

https://www.bbc.co.uk/news/technology-56713017

Excellent read, Everybody Make a cup of Tea and take 10 minutes to read this.

Both will make you feel a lot better.

[thx Kaeren - will repost your link]

https://www.powerof78.com/2021/04/11/ncyt-blackbird-investing/

I thought that the Webinar we hosted 5/6 weeks ago with 3/4 distinguished speakers would reinforce our products (PCR over LFT) etc, etc to everybody in the Governments/DHSC decision making teams?

Another one on 7th May will be interesting.
https://twitter.com/NovacytGroup/status/1380436575977402371/photo/1

Millions of PCR tests needed for travel. Timing it right to take the test, get the results will need planning, before travelling.
(Can feel Backlog coming)

For England, destination countries will be in one of three categories:

Green: Passengers will not need to quarantine on return, but must take a pre-departure test, as well as a PCR test on return to the UK

Amber: Travellers will need to quarantine for 10 days, as well as taking a pre-departure test and "TWO" PCR tests

Red: Passengers will have to pay for a 10-day stay in a managed quarantine hotel, as well as a pre-departure test and "TWO" PCR tests. About 40 countries are on the current "red list"

Cant imagine there will be Much (if Any) Air travel to/from the African Continent with PCR tests!!!

correction:
Cant imagine there will be Much (if Any) Air travel to/from the African Continent WITHOUT PCR tests this YEAR!!!

And now believe there is a "Nigerian Variant" (similar (but not the same) as South African Variant) to be confirmed in next few weeks here.

Cant imagine there will be Much (if Any) Air travel to/from the African Continent with PCR tests!!!

So perhaps now GM/Mandy/PR Team can issue some RNS's & Updates like they did in Q1 2020.

Keep the investors informed!!!

or what about a Share BUY Back by NCYT?

Bargain TakeOver value here ?

71m shares x £15 each = £1.07billion

Company has £120m cash in bank + £33m for Q2, Q3 & Q4 expected (minimum) = £200m for Y/E

Yes, we're still a £150m - £200m p.a. company and we can grow further.

"Europe & Travel World" want PCR tests, the best is us.

Whose going to identify the new variants? - NCYT

Still a lot going in our favour